Welcome to LookChem.com Sign In|Join Free

CAS

  • or

162051-22-1

Post Buying Request

162051-22-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

162051-22-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 162051-22-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,2,0,5 and 1 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 162051-22:
(8*1)+(7*6)+(6*2)+(5*0)+(4*5)+(3*1)+(2*2)+(1*2)=91
91 % 10 = 1
So 162051-22-1 is a valid CAS Registry Number.

162051-22-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-[2-(dimethylamino)ethyl]-5,5-diphenyloxolan-2-one

1.2 Other means of identification

Product number -
Other names 3-(2-(Dimethylamino)ethyl)dihydro-5,5-diphenyl-2(3H)-furanone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:162051-22-1 SDS

162051-22-1Downstream Products

162051-22-1Relevant articles and documents

Mechanism(s) of pharmacological action of an α-(aminoethyl)-γ-butyrolactone. In vivo studies in mice

Kolocouris,Fytas,Foscolos,Kalliteraki,Vamvakides

, p. 516 - 520 (2007/10/02)

This paper describes the synthesis of α-(dimethylaminoethyl)-γ,γ-diphenyl-γ-butyrolactone 4. The study of convulsions induced, on mice, by this compound could show the existence of antiGABAergic and cholinergic action components, but, unlike the homologous α-(dialkylaminomethyl)-γ-butyrolactones (with one -CH2- less on the aminoalkyl chain), no antiglycinergic component was detected. The effects of atropine on the aminolactone 4 induced convulsions (antagonism 5 mn and synergy 30 mn after atropine) could suggest an activation of the glutamatergic receptors (NMDA), by indirect stimulation of their glycinergic site, by the aminolactone 4.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 162051-22-1